Trials / Unknown
UnknownNCT05001061
Sublingual vs Vaginal Misoprostol for Termination of First Trimesteric Missed Abortion
- Status
- Unknown
- Phase
- EARLY_Phase 1
- Study type
- Interventional
- Enrollment
- 288 (estimated)
- Sponsor
- Cairo University · Academic / Other
- Sex
- Female
- Age
- 18 Years – 45 Years
- Healthy volunteers
- Accepted
Summary
Efficacy of sublingual versus vaginal misoprostol in termination of first trimester missed abortion
Detailed description
study will be made on female patients with first trimester missed abortion confirmed by ultrasound . Participants will be divided into 2 groups one group (A) will receive sublingual Misoprostol and the other group(B) will receive vaginal Misoprostol as a 800 micro grams every 4 hours in both groups up to five doses the aim of the study is to compare efficay of sublingual and vaginal Misoprostol in complete termination of first trimester missed abortion and which route is the best will less side effects.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Misoprostol Pill | sublingual versus vaginal Misoprostol in termination of first trimester missed abortion |
Timeline
- Start date
- 2021-08-03
- Primary completion
- 2021-10-15
- Completion
- 2021-10-16
- First posted
- 2021-08-11
- Last updated
- 2021-08-11
Source: ClinicalTrials.gov record NCT05001061. Inclusion in this directory is not an endorsement.